# FOXC1

## Overview
FOXC1 is a gene that encodes the forkhead box C1 protein, a member of the forkhead box (FOX) family of transcription factors. This protein is characterized by a conserved forkhead domain, which is essential for its role in DNA binding and transcriptional regulation (Pierrou1994Cloning; Saleem2001Analyses). The FOXC1 protein is involved in various biological processes, particularly in the development and function of the eye's anterior segment, where it plays a critical role in maintaining cellular homeostasis and regulating oxidative stress responses (Berry2007FOXC1). Mutations in the FOXC1 gene are linked to several ocular and systemic disorders, including Axenfeld-Rieger syndrome and primary congenital glaucoma, underscoring its clinical significance (Siggs2019Prevalence; Saleem2003Identification). The protein's interactions and post-translational modifications further modulate its activity, highlighting its complex regulatory mechanisms (Yang2017FOXC1).

## Structure
The FOXC1 protein is a member of the forkhead box (FOX) family, characterized by a conserved forkhead domain (FHD), a 110-amino-acid DNA-binding motif. This domain is a variant of the helix-turn-helix motif, known as the 'winged helix,' and consists of three alpha helices and two large loops forming 'wing' structures (Pierrou1994Cloning; Saleem2001Analyses). The FHD is crucial for DNA binding and transactivation functions, with specific mutations in this domain affecting these capabilities (Saleem2003Identification).

The FOXC1 protein is composed of 553 amino acids and contains modular transcription activation domains at both the N and C termini, as well as a transcription inhibitory domain adjacent to the FHD (Saleem2003Identification). The protein's tertiary structure involves a winged-helical bundle, with hydrophobic interactions playing a key role in maintaining its stability. Key residues involved in these interactions include Leu 86, Ile 87, Ile 104, Phe 107, Ile 108, Ile 126, Leu 130, Phe 151, and Trp 152, which are conserved between FOXC1 and the rat Genesis protein, used as a structural template (Saleem2001Analyses).

Mutations in the FOXC1 protein, such as L86F and I87M, can significantly impact its DNA-binding and transactivation functions without affecting nuclear localization, highlighting the importance of precise structural integrity for its function (Saleem2001Analyses; Saleem2003Identification). The protein's structure is essential for its role in transcription regulation, with alterations potentially leading to developmental disorders.

## Function
The FOXC1 gene encodes a transcription factor that plays a crucial role in maintaining cellular homeostasis in the eye. It is involved in the transcriptional regulation of several genes, including FOXO1A, which is important for cellular stress response and apoptotic pathways. FOXC1 binds to a conserved element in the FOXO1A promoter, and its expression is necessary for the proper expression of FOXO1A in human trabecular meshwork (TM) cells (Berry2007FOXC1). This regulation is essential for cell viability and resistance to oxidative stress, as reduced FOXC1 expression leads to decreased FOXO1A levels, impaired cellular responses to oxidative stress, and increased cell death (Berry2007FOXC1).

FOXC1 is also involved in the development and function of the anterior segment of the eye. It is expressed in the periocular mesenchyme during eye development and is necessary for the correct formation of structures such as the trabecular meshwork, which is crucial for maintaining intraocular pressure (Berry2007FOXC1; Paylakhi2013FOXC1). The gene's role in regulating oxidative stress resistance is highlighted by its involvement in detoxifying reactive oxygen species and maintaining TM cell viability, which is crucial for preventing glaucomatous damage (Berry2007FOXC1).

## Clinical Significance
Mutations in the FOXC1 gene are associated with a range of ocular and systemic conditions, most notably Axenfeld-Rieger syndrome (ARS). ARS is characterized by anterior segment dysgenesis, which includes iris hypoplasia, corectopia, and glaucoma, as well as systemic features such as dental anomalies and congenital cardiac defects (Acharya2011A; Weisschuh2006Novel; Saleem2003Identification). The gene's mutations can be missense, nonsense, frameshift, or involve chromosomal rearrangements, affecting the protein's DNA-binding and transactivation abilities (Tümer2009Axenfeld–Rieger; Lehmann2000Chromosomal).

FOXC1 mutations are also linked to primary congenital glaucoma and other ocular conditions like Peters anomaly and Fuchs' endothelial dystrophy (Tümer2009Axenfeld–Rieger; Siggs2019Prevalence). These mutations can lead to dosage sensitivity, where both deletions and duplications of the gene result in disease through mechanisms such as haploinsufficiency or altered repression activity (Tümer2009Axenfeld–Rieger).

Alterations in FOXC1 expression levels are implicated in congenital heart defects and certain cancers, highlighting the gene's broader clinical significance beyond ocular disorders (Acharya2011A). The phenotypic variability observed in conditions associated with FOXC1 mutations suggests the influence of additional genetic and environmental factors (Weisschuh2006Novel).

## Interactions
FOXC1 is known to interact with the PITX2 protein, forming a physical complex that plays a crucial role in eye development. This interaction is significant as it involves the C-terminal activation domain of FOXC1 and the homeodomain of PITX2A, suggesting a common pathway that explains the similar phenotypes caused by mutations in these genes (Berry2006Functional). The FOXC1-PITX2 complex is colocalized within a restricted subset of chromatin, indicating that their activities are functionally interconnected. PITX2 can negatively regulate the transcriptional activation potential of FOXC1, which is important for understanding the sensitivity to FOXC1 dosage in the eye (Berry2006Functional).

FOXC1 also undergoes post-translational modifications that affect its interactions and functions. Phosphorylation at Ser-272, mediated by ERK1/2, is crucial for its transcriptional activation in response to epidermal growth factor (EGF). This phosphorylation can alter FOXC1's mobility and transcriptional activity, and it impedes the interaction between FOXC1 and E3-ubiquitin ligase, suggesting a regulatory mechanism for its stability (Yang2017FOXC1). FOXC1 is also modified by small ubiquitin-like modifier (SUMO) proteins, specifically SUMO2 and SUMO3, which inhibit its activity (Yang2017FOXC1).


## References


[1. (Weisschuh2006Novel) Nicole Weisschuh, Paul Dressler, Frank Schuettauf, Christiane Wolf, Bernd Wissinger, and Eugen Gramer. Novel mutations offoxc1andpitx2in patients with axenfeld-rieger malformations. Investigative Opthalmology &amp; Visual Science, 47(9):3846, September 2006. URL: http://dx.doi.org/10.1167/iovs.06-0343, doi:10.1167/iovs.06-0343. This article has 38 citations.](https://doi.org/10.1167/iovs.06-0343)

[2. (Saleem2001Analyses) Ramsey A. Saleem, Sharmila Banerjee-Basu, Fred B. Berry, Andreas D. Baxevanis, and Michael A. Walter. Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein foxc1. The American Journal of Human Genetics, 68(3):627–641, March 2001. URL: http://dx.doi.org/10.1086/318792, doi:10.1086/318792. This article has 108 citations.](https://doi.org/10.1086/318792)

[3. (Saleem2003Identification) Ramsey A. Saleem, Tara C. Murphy, Jeffery M. Liebmann, and Michael A. Walter. Identification and analysis of a novel mutation in the foxc1 forkhead domain. Investigative Opthalmology &amp; Visual Science, 44(11):4608, November 2003. URL: http://dx.doi.org/10.1167/IOVS.03-0090, doi:10.1167/iovs.03-0090. This article has 47 citations.](https://doi.org/10.1167/IOVS.03-0090)

[4. (Yang2017FOXC1) Zhi Yang, Shuai Jiang, Yicheng Cheng, Tian Li, Wei Hu, Zhiqiang Ma, Fulin Chen, and Yang Yang. Foxc1 in cancer development and therapy: deciphering its emerging and divergent roles. Therapeutic Advances in Medical Oncology, 9(12):797–816, November 2017. URL: http://dx.doi.org/10.1177/1758834017742576, doi:10.1177/1758834017742576. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1758834017742576)

[5. (Acharya2011A) Moulinath Acharya, LiJia Huang, Valerie C. Fleisch, W. Ted Allison, and Michael A. Walter. A complex regulatory network of transcription factors critical for ocular development and disease. Human Molecular Genetics, 20(8):1610–1624, January 2011. URL: http://dx.doi.org/10.1093/hmg/ddr038, doi:10.1093/hmg/ddr038. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddr038)

[6. (Lehmann2000Chromosomal) Ordan J. Lehmann, Neil D. Ebenezer, Tim Jordan, Margaret Fox, Louise Ocaka, Annette Payne, Bart P. Leroy, Brian J. Clark, Roger A. Hitchings, Sue Povey, Peng T. Khaw, and Shomi S. Bhattacharya. Chromosomal duplication involving the forkhead transcription factor gene foxc1 causes iris hypoplasia and glaucoma. The American Journal of Human Genetics, 67(5):1129–1135, November 2000. URL: http://dx.doi.org/10.1016/s0002-9297(07)62943-7, doi:10.1016/s0002-9297(07)62943-7. This article has 32 citations.](https://doi.org/10.1016/s0002-9297(07)62943-7)

[7. (Berry2006Functional) Fred B. Berry, Matthew A. Lines, J. Martin Oas, Tim Footz, D. Alan Underhill, Philip J. Gage, and Michael A. Walter. Functional interactions between foxc1 and pitx2 underlie the sensitivity to foxc1 gene dose in axenfeld–rieger syndrome and anterior segment dysgenesis. Human Molecular Genetics, 15(6):905–919, January 2006. URL: http://dx.doi.org/10.1093/hmg/ddl008, doi:10.1093/hmg/ddl008. This article has 169 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddl008)

[8. (Tümer2009Axenfeld–Rieger) Zeynep Tümer and Daniella Bach-Holm. Axenfeld–rieger syndrome and spectrum of pitx2 and foxc1 mutations. European Journal of Human Genetics, 17(12):1527–1539, June 2009. URL: http://dx.doi.org/10.1038/ejhg.2009.93, doi:10.1038/ejhg.2009.93. This article has 301 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2009.93)

[9. (Siggs2019Prevalence) Owen M. Siggs, Emmanuelle Souzeau, Francesca Pasutto, Andrew Dubowsky, James E. H. Smith, Deepa Taranath, John Pater, Julian L. Rait, Andrew Narita, Lucia Mauri, Alessandra Del Longo, André Reis, Angela Chappell, Lisa S. Kearns, Sandra E. Staffieri, James E. Elder, Jonathan B. Ruddle, Alex W. Hewitt, Kathryn P. Burdon, David A. Mackey, and Jamie E. Craig. Prevalence offoxc1variants in individuals with a suspected diagnosis of primary congenital glaucoma. JAMA Ophthalmology, 137(4):348, April 2019. URL: http://dx.doi.org/10.1001/jamaophthalmol.2018.5646, doi:10.1001/jamaophthalmol.2018.5646. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1001/jamaophthalmol.2018.5646)

[10. (Berry2007FOXC1) Fred B. Berry, Jonathan M. Skarie, Farideh Mirzayans, Yannick Fortin, Thomas J. Hudson, Vincent Raymond, Brian A. Link, and Michael A. Walter. Foxc1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of foxo1a. Human Molecular Genetics, 17(4):490–505, November 2007. URL: http://dx.doi.org/10.1093/hmg/ddm326, doi:10.1093/hmg/ddm326. This article has 84 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddm326)

[11. (Pierrou1994Cloning) S. Pierrou, M. Hellqvist, L. Samuelsson, S. Enerbäck, and P. Carlsson. Cloning and characterization of seven human forkhead proteins: binding site specificity and dna bending. The EMBO Journal, 13(20):5002–5012, October 1994. URL: http://dx.doi.org/10.1002/j.1460-2075.1994.tb06827.x, doi:10.1002/j.1460-2075.1994.tb06827.x. This article has 341 citations.](https://doi.org/10.1002/j.1460-2075.1994.tb06827.x)

[12. (Paylakhi2013FOXC1) Seyed Hassan Paylakhi, Hamidreza Moazzeni, Shahin Yazdani, Paniz Rassouli, Ehsan Arefian, Elham Jaberi, Emad Heidari Arash, Ahmad Sadighi Gilani, Jian-Bing Fan, Craig April, Sadaf Amin, Fatemeh Suri, and Elahe Elahi. Foxc1 in human trabecular meshwork cells is involved in regulatory pathway that includes mir-204, meis2, and itgβ1. Experimental Eye Research, 111:112–121, June 2013. URL: http://dx.doi.org/10.1016/j.exer.2013.03.009, doi:10.1016/j.exer.2013.03.009. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exer.2013.03.009)